DHCR24 and melanoma: In the present study, based on IHC results from clinical tissue microarray, DHCR24 was found to be highly expressed in melanoma patients, and knocking down DHCR24 blocked the cells in S phase and inhibited the proliferation and migration of melanoma cells.